Compare · AIDX vs ULS
AIDX vs ULS
Side-by-side comparison of 20/20 Biolabs Inc. (AIDX) and UL Solutions Inc. (ULS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AIDX and ULS operate in Precision Instruments (Health Care), so they compete in similar markets.
- ULS is the larger of the two at $19.56B, about 2187.4x AIDX ($8.9M).
- Over the past year, AIDX is down 95.9% and ULS is up 37.7% - ULS leads by 133.6 points.
- ULS has been more active in the news (20 items in the past 4 weeks vs 10 for AIDX).
- ULS has more recent analyst coverage (6 ratings vs 0 for AIDX).
PerformanceAIDX-95.89%ULS+17.23%
2026-02-19+0.00%2026-06-08
- Company
- 20/20 Biolabs Inc.
- UL Solutions Inc.
- Price
- $0.84+1.51%
- $97.08+0.26%
- Market cap
- $8.9M
- $19.56B
- 1M return
- -38.95%
- -2.28%
- 1Y return
- -95.89%
- +37.74%
- Industry
- Precision Instruments
- Precision Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2024
- News (4w)
- 10
- 20
- Recent ratings
- 0
- 6
Latest AIDX
- SEC Form PRE 14A filed by 20/20 Biolabs Inc.
- 20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters
- 20/20 Biolabs Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- 20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand
- SEC Form 424B3 filed by 20/20 Biolabs Inc.
- SEC Form 424B3 filed by 20/20 Biolabs Inc.
- SEC Form 10-Q filed by 20/20 Biolabs Inc.
- 20/20 Biolabs Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- 20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress
- Sidoti Events, LLC's May Micro-Cap Virtual Conference
Latest ULS
- Officer Schjotz Gitte sold $2,154,723 worth of shares (21,880 units at $98.48) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 59,341 units (SEC Form 4)
- President and CEO Scanlon Jennifer F. sold $1,249,983 worth of shares (12,500 units at $100.00) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 176,724 units (SEC Form 4)
- UL Solutions Inc. filed SEC Form 8-K: Leadership Update
- Executive VP & CFO Robinson Ryan D gifted 29,268 shares and received a gift of 29,268 shares, decreasing direct ownership by 96% to 1,290 units (SEC Form 4)
- EVP & CCO Uggetti Alberto sold $234,242 worth of shares (2,345 units at $99.89) as part of a pre-agreed trading plan, decreasing direct ownership by 23% to 7,962 units (SEC Form 4)
- UL Solutions to Attend Upcoming Investor Conferences
- SEC Form 4 filed by Director Williams George A
- SEC Form 4 filed by Director Torstad Elisabeth
- SEC Form 4 filed by Director Susman Sally
- Director Thaman Michael H converted options into 2,805 shares, increasing direct ownership by 20% to 16,660 units (SEC Form 4)